European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms: reponse to the comments from the Francophone Group of Hematological Cytogenetics (GFCH)

K. A. Rack; E. van den Berg; C. Haferlach; H. B. Beverloo; D. Costa; B. Espinet; N. Foot; S. Jeffries; K. Martin; S. O'Connor; J. Schoumans; P. Talley; N. Telford; S. Stioui; Z. Zemanova; R. J. Hastings

doi:10.1038/s41375-020-0736-x

European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms: reponse to the comments from the Francophone Group of Hematological Cytogenetics (GFCH)

K. A. Rack
, E. van den Berg
, C. Haferlach
, H. B. Beverloo
, D. Costa
, B. Espinet
, N. Foot
, S. Jeffries
, K. Martin
, S. O'Connor
, J. Schoumans
, P. Talley
, N. Telford
, S. Stioui
, Z. Zemanova
, R. J. Hastings^*

^*Corresponding author for this work

Research output: Contribution to journal › Letter (Research letter) › Academic › peer-review

12 Citations (Scopus)

85 Downloads (Pure)

Original language	English
Pages (from-to)	2262-2264
Number of pages	3
Journal	Leukemia
Volume	34
Issue number	8
DOIs	https://doi.org/10.1038/s41375-020-0736-x
Publication status	Published - 7-Feb-2020

Access to Document

10.1038/s41375-020-0736-xLicence: CC BY

European recommendations and quality assurance for cytogenomic analysis of haematological neoplasmsFinal publisher's version, 227 KBLicence: CC BY

Handle.net

Persistent link

Cite this

Rack, K. A., van den Berg, E., Haferlach, C., Beverloo, H. B., Costa, D., Espinet, B., Foot, N., Jeffries, S., Martin, K., O'Connor, S., Schoumans, J., Talley, P., Telford, N., Stioui, S., Zemanova, Z., & Hastings, R. J. (2020). European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms: reponse to the comments from the Francophone Group of Hematological Cytogenetics (GFCH). Leukemia, 34(8), 2262-2264. https://doi.org/10.1038/s41375-020-0736-x

@article{894823a62d994d6f9862a18dbb9d6caf,

title = "European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms: reponse to the comments from the Francophone Group of Hematological Cytogenetics (GFCH)",

author = "Rack, \{K. A.\} and \{van den Berg\}, E. and C. Haferlach and Beverloo, \{H. B.\} and D. Costa and B. Espinet and N. Foot and S. Jeffries and K. Martin and S. O'Connor and J. Schoumans and P. Talley and N. Telford and S. Stioui and Z. Zemanova and Hastings, \{R. J.\}",

year = "2020",

month = feb,

day = "7",

doi = "10.1038/s41375-020-0736-x",

language = "English",

volume = "34",

pages = "2262--2264",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "8",

}

Rack, KA, van den Berg, E, Haferlach, C, Beverloo, HB, Costa, D, Espinet, B, Foot, N, Jeffries, S, Martin, K, O'Connor, S, Schoumans, J, Talley, P, Telford, N, Stioui, S, Zemanova, Z & Hastings, RJ 2020, 'European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms: reponse to the comments from the Francophone Group of Hematological Cytogenetics (GFCH)', Leukemia, vol. 34, no. 8, pp. 2262-2264. https://doi.org/10.1038/s41375-020-0736-x

European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms: reponse to the comments from the Francophone Group of Hematological Cytogenetics (GFCH). / Rack, K. A.; van den Berg, E.; Haferlach, C. et al.
In: Leukemia, Vol. 34, No. 8, 07.02.2020, p. 2262-2264.

Research output: Contribution to journal › Letter (Research letter) › Academic › peer-review

TY - JOUR

T1 - European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms

T2 - reponse to the comments from the Francophone Group of Hematological Cytogenetics (GFCH)

AU - Rack, K. A.

AU - van den Berg, E.

AU - Haferlach, C.

AU - Beverloo, H. B.

AU - Costa, D.

AU - Espinet, B.

AU - Foot, N.

AU - Jeffries, S.

AU - Martin, K.

AU - O'Connor, S.

AU - Schoumans, J.

AU - Talley, P.

AU - Telford, N.

AU - Stioui, S.

AU - Zemanova, Z.

AU - Hastings, R. J.

PY - 2020/2/7

Y1 - 2020/2/7

U2 - 10.1038/s41375-020-0736-x

DO - 10.1038/s41375-020-0736-x

M3 - Letter (Research letter)

SN - 0887-6924

VL - 34

SP - 2262

EP - 2264

JO - Leukemia

JF - Leukemia

IS - 8

ER -